Synthesis of NIR/SWIR Absorbing InSb Nanocrystals Using Indium(I) Halide and Aminostibine Precursors

Abstract

AbstractColloidal InSb quantum dots (QDs) are a potential alternative to toxic Pb‐ and Hg‐chalcogenide QDs for covering the technologically important near‐infrared/shortwave infrared (NIR/SWIR) spectral range. However, appropriate Sb precursors are scarce and obtaining narrow size distributions is challenging. Tris(dimethylamido)antimony (Sb(NMe2)3) is an appealing choice due to its commercial availability and non‐pyrophoric character but implies the reduction of antimony from the +3 to the required –3 state. In reported works, strong reducing agents such as lithium triethylborohydride are used, which lead to the fast co‐reduction of both Sb3+ and In3+. The downsides of this approach are reproducibility issues and the risk of forming metal nanoparticles due to the different reduction kinetics of Sb3+ and In3+. Here, indium(I) halides are explored as simultaneous indium source and mild reducing agent for the antimony precursor. The wavelength of the excitonic absorption peak of the phase‐pure InSb QDs obtained with this approach can be tuned from 630 to 1890 nm, which corresponds to a size range of ≈2–7 nm. The synthesis can also be conducted in a heat‐up manner, which facilitates the scale‐up and paves the way for the use of InSb QDs in applications such as NIR/SWIR photodetectors, cameras, biological imaging, and telecommunications.